Literature DB >> 31765054

Bioluminescence Profiling of NanoKAZ/NanoLuc Luciferase Using a Chemical Library of Coelenterazine Analogues.

Eloi P Coutant1, Glwadys Gagnot1,2, Vincent Hervin1, Racha Baatallah1, Sophie Goyard3, Yves Jacob4, Thierry Rose3, Yves L Janin1.   

Abstract

We describe here an extensive structure-bioluminescence relationship study of a chemical library of analogues of coelenterazine, using nanoKAZ/NanoLuc, a mutated luciferase originated from the catalytic subunit of the deep-sea shrimp Oplophorus gracilirostris. Out of the 135 O-acetylated precursors that were prepared by using our recently reported synthesis and following their hydrolysis to give solutions of the corresponding luciferins, notable bioluminescence improvements were achieved in comparison with furimazine, which is currently amongst the best substrates of nanoKAZ/NanoLuc. For instance, the rather more lipophilic analogue 8-(2,3-difluorobenzyl)-2-((5-methylfuran-2-yl)methyl)-6-phenylimidazo[1,2-a]pyrazin-3(7H)-one provided a 1.5-fold improvement of the total light output over a 2 h period, a close to threefold increase of the initial signal intensity and a signal-to-background ratio five times greater than furimazine. The kinetic parameters for the enzymatic reaction were obtained for a selection of luciferin analogues and provided unexpected insights into the luciferase activity. Most prominently, along with a general substrate-dependent and irreversible inactivation of this enzyme, in the case of the optimized luciferin mentioned above, the consumption of 2664 molecules was found to be required for the detection of a single Relative Light Unit (RLU; a luminometer-dependent fraction of a photon).
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  enzyme catalysis; heterocycles; luciferins; luminescence; natural products

Year:  2020        PMID: 31765054     DOI: 10.1002/chem.201904844

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  10 in total

1.  Measuring the subcellular compartmentalization of viral infections by protein complementation assay.

Authors:  Juliette Fernandez; Cédric Hassen-Khodja; Virginie Georget; Thierry Rose; Yves Jacob; Yves L Janin; Sébastien Nisole; Pierre-Olivier Vidalain; Nathalie J Arhel
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-12       Impact factor: 11.205

2.  A proteome-scale map of the SARS-CoV-2-human contactome.

Authors:  Dae-Kyum Kim; Benjamin Weller; Chung-Wen Lin; Dayag Sheykhkarimli; Jennifer J Knapp; Guillaume Dugied; Andreas Zanzoni; Carles Pons; Marie J Tofaute; Sibusiso B Maseko; Kerstin Spirohn; Florent Laval; Luke Lambourne; Nishka Kishore; Ashyad Rayhan; Mayra Sauer; Veronika Young; Hridi Halder; Nora Marín-de la Rosa; Oxana Pogoutse; Alexandra Strobel; Patrick Schwehn; Roujia Li; Simin T Rothballer; Melina Altmann; Patricia Cassonnet; Atina G Coté; Lena Elorduy Vergara; Isaiah Hazelwood; Betty B Liu; Maria Nguyen; Ramakrishnan Pandiarajan; Bushra Dohai; Patricia A Rodriguez Coloma; Juline Poirson; Paolo Giuliana; Luc Willems; Mikko Taipale; Yves Jacob; Tong Hao; David E Hill; Christine Brun; Jean-Claude Twizere; Daniel Krappmann; Matthias Heinig; Claudia Falter; Patrick Aloy; Caroline Demeret; Marc Vidal; Michael A Calderwood; Frederick P Roth; Pascal Falter-Braun
Journal:  Nat Biotechnol       Date:  2022-10-10       Impact factor: 68.164

3.  BIKE regulates dengue virus infection and is a cellular target for broad-spectrum antivirals.

Authors:  Szuyuan Pu; Stanford Schor; Marwah Karim; Sirle Saul; Makeda Robinson; Sathish Kumar; Laura I Prugar; Danielle E Dorosky; Jennifer Brannan; John M Dye; Shirit Einav
Journal:  Antiviral Res       Date:  2020-11-01       Impact factor: 5.970

4.  Peripheral natural killer cells in chronic hepatitis B patients display multiple molecular features of T cell exhaustion.

Authors:  Marie Marotel; Marine Villard; Annabelle Drouillard; Issam Tout; Laurie Besson; Omran Allatif; Marine Pujol; Yamila Rocca; Michelle Ainouze; Guillaume Roblot; Sébastien Viel; Melissa Gomez; Veronique Loustaud; Sophie Alain; David Durantel; Thierry Walzer; Uzma Hasan; Antoine Marçais
Journal:  Elife       Date:  2021-01-28       Impact factor: 8.140

Review 5.  How to Select Firefly Luciferin Analogues for In Vivo Imaging.

Authors:  Ryohei Saito-Moriya; Jun Nakayama; Genta Kamiya; Nobuo Kitada; Rika Obata; Shojiro A Maki; Hiroshi Aoyama
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

6.  The transcriptional landscape of Venezuelan equine encephalitis virus (TC-83) infection.

Authors:  Zhiyuan Yao; Fabio Zanini; Sathish Kumar; Marwah Karim; Sirle Saul; Nishank Bhalla; Nuttada Panpradist; Avery Muniz; Aarthi Narayanan; Stephen R Quake; Shirit Einav
Journal:  PLoS Negl Trop Dis       Date:  2021-03-31

7.  On Reuben G. Jones synthesis of 2-hydroxypyrazines.

Authors:  Pierre Legrand; Yves L Janin
Journal:  Beilstein J Org Chem       Date:  2022-07-29       Impact factor: 2.544

8.  Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies.

Authors:  Marwah Karim; Sirle Saul; Luca Ghita; Malaya Kumar Sahoo; Chengjin Ye; Nishank Bhalla; Chieh-Wen Lo; Jing Jin; Jun-Gyu Park; Belén Martinez-Gualda; Michael Patrick East; Gary L Johnson; Benjamin A Pinsky; Luis Martinez-Sobrido; Christopher R M Asquith; Aarthi Narayanan; Steven De Jonghe; Shirit Einav
Journal:  Antiviral Res       Date:  2022-06-20       Impact factor: 10.103

Review 9.  Coelenterazine-Dependent Luciferases as a Powerful Analytical Tool for Research and Biomedical Applications.

Authors:  Vasilisa V Krasitskaya; Eugenia E Bashmakova; Ludmila A Frank
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

10.  High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris.

Authors:  François Anna; Sophie Goyard; Ana Ines Lalanne; Fabien Nevo; Marion Gransagne; Philippe Souque; Delphine Louis; Véronique Gillon; Isabelle Turbiez; François-Clément Bidard; Aline Gobillion; Alexia Savignoni; Maude Guillot-Delost; François Dejardin; Evelyne Dufour; Stéphane Petres; Odile Richard-Le Goff; Zaineb Choucha; Olivier Helynck; Yves L Janin; Nicolas Escriou; Pierre Charneau; Franck Perez; Thierry Rose; Olivier Lantz
Journal:  Eur J Immunol       Date:  2020-12-23       Impact factor: 6.688

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.